Prof. Dr. Milica Popović delivered a lecture at the 62nd Oncology Week within the “Scientific Projects in Serbia” session, where she presented the achievements and vision of the EXPAND-EV project. Her presentation highlighted how extracellular-vesicle-based technologies are advancing from fundamental research toward clinical translation in oncology, emphasizing biomarker development, therapeutic loading strategies and next-generation EV platforms. The lecture showcased EXPAN

Members of our consortium represented the EXPAND-EV project at the 1st Regional SDIR–HDIR–MOKAD Congress , held in Belgrade, Serbia, from October 8–10, 2025. This inaugural regional congress brought together researchers and clinicians from the Serbian (SDIR), Croatian (HDIR), and Turkish (MOKAD) cancer research societies, all affiliated with the European Association for Cancer Research (EACR) . The event served as a vibrant platform for sharing cutting-edge discoveries, discu

From 7–10 October 2025, researchers Lidija Filipović and Jovana Terzić from UBFC and ICTM represented the EXPAND-EV Project at the 3rd MOVE Symposium  held in Tartu, Estonia. The event was hosted by the Baltic Society of Extracellular Vesicles (BSEV)  and organized by the European National Societies of Extracellular Vesicles (NEVS), bringing together experts from across Europe to discuss the latest advances in extracellular vesicle (EV) research. Lidija and Jovana presented

Dr. Lidija Filipović from partner Faculty of Chemistry University of Belgrade (UBFC) received the Stanka Romac Prize for the best PhD thesis in the field of Human Molecular Genetics and Biomedicine, carried out in scientific research institutions in Serbia. The award was granted by the FOSTAR Foundation for the academic year 2024/2025. This recognition is both a personal achievement for Dr. Filipović and a collective success for the entire EXPAND-EV team. It demonstrates th

Dr. Milena Čavić from partner IORS participated as an Invited Lecturer at the “Precision Public Health and Innovative Approaches in Cancer Prevention: Implications for Public Health Policy” meeting organized on Sept 3, 2025, by the Red Cross Serbia and the School of Medicine, University of Belgrade, Serbia . The event emphasized the importance of integrating innovative approaches into public health policy, thereby opening new directions for the development of cancer preven

Welcome to the first edition of the EXPAND-EV Newsletter ! Discover the latest updates from the initial months of our project and stay...

Dr. Milena Čavić from IORS participated as a lecturer at the Info Day of the International Cooperation and Project Office (ICPO) of the Institute for Chemistry, Technology and Metallurgy, National Institute of the Republic of Serbia, on August 27, 2025. During the event, drafts of the WIDERA 2026–2027 work programs were presented, along with key information on funding through the lump sum model, two-factor authentication on the F&T portal, and ongoing projects, including EX

On May 15th, 2025, Dr. Anđelo Beletić from Genos Ltd. had the privilege of being invited by his host, Dr. Joaquin Seras Franzoso—Principal Investigator of the Clinical Biochemistry, Drug Delivery & Therapy (CB- DT) group at Fundació Hospital Universitari Vall d'Hebron – Institut de Recerca (VHIR)— to peak at the institution’s well-known ‘Vall d'Hebron Talks by VHIR‘ series ( https://vhir.vallhebron.com/ca/societat/activitats/vall-dhebron-talks-vhir-deciphering-igg-glycome-sw

On May 9, 2025, Dr. Lidija Filipović from our partner UBFC successfully defended her PhD dissertation titled “Purification of Extracellular Vesicles Using Immunoaffinity Methods and Their Characterization.”  Her work was conducted under the supervision of Dr. Milica Popović. The dissertation was part of the research project which focused on developing advanced techniques for the isolation and characterization of extracellular vesicles (EVs). The findings support further unde

The first UMOS-SDIR Colloquium on Liquid Biopsy in Oncology, organized by the Association of Medical Oncologists of Serbia (UMOS) and the Serbian Association for Cancer Research (SDIR) was held on February 26, 2025. The colloquium provided a forum for experts to discuss the challenges associated with liquid biopsy, arising from the continuous advancements in cancer research and clinical oncology, as well as potential solutions that have not yet been incorporated into official

On January 30, 2025, Dr. Milena Čavić from partner IORS , delivered an insightful lecture at the Centre for Translational Cancer Research titled: "Personalized Medicine and Molecular Diagnostics Approaches in Profiling of Solid Tumors in Serbia." The lecture focused on the latest advancements in molecular diagnostics and personalised medicine, with a special emphasis on the importance of scientific projects, such as EXPAND-EV, in shaping the field. Dr. Čavić highlighted how i